ZIM LABORATORIES
Back to Balance Sheet
|
ZIM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹53 Cr | ₹49 Cr | ₹30 Cr | ₹20 Cr | ₹19 Cr |
What is the latest Total Non-Current Liabilities ratio of ZIM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹53 Cr |
| Mar2024 | ₹49 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹19 Cr |
How is Total Non-Current Liabilities of ZIM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹53 Cr | 9.80 | |
| Mar2024 | ₹49 Cr | 59.79 | |
| Mar2023 | ₹30 Cr | 52.16 | |
| Mar2022 | ₹20 Cr | 3.12 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Non-Current Liabilities of peers of ZIM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZIM LABORATORIES | ₹356.1 Cr | 5.1% | -2.4% | -34.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
ZIM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZIM LABORATORIES | 5.1% |
-2.4% |
-34.2% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses